Minitablets Manufacturing Characterization Methods and Future Opportunities
Keynote SeriesPharmaceutical Technology is sponsoring a sponsoring a Keynote Series session on innovations in solid dosage development and manufacturing on the INTERPHEX 2016 Exhibit Hall Innovation Stage. Admission is free to any attendee with an exhibit hall pass.
Keynote SeriesPharmaceutical Technology is sponsoring a sponsoring a Keynote Series session on innovations in solid dosage development and manufacturing on the INTERPHEX 2016 Exhibit Hall Innovation Stage. Admission is free to any attendee with an exhibit hall pass.
Tuesday, April 26
Innovations in Solid Dosage Development and Manufacturing
Oral solid-dosage forms are the leading drug delivery method, but new development and manufacturing technologies are offering new options for patients. Experts will discuss advances in new solid dosage forms.
2:20–2:50 pm
Minitablets: Manufacturing, Characterization Methods and Future Opportunities
The use of a multiparticulate-based system can be beneficial in designing a patient-centric dosage form; one such dosage form is minitablets, which are compressed tablets with typical diameters of two to four millimeters. Minitablets have many applications, including as a pediatric dosage form, for patients with dysphagia, and where rapid and/or flexible dose adjustments are needed including combination therapies. Variations of the tablet formulation and coating systems can also deliver dosage forms with specific functionalities such as orally disintegrating tablets (ODTs), extended release formulations, or GI-targeted systems. The manufacturing techniques used to produce minitablet-based dosage forms are essentially the same as the processes employed in pharmaceutical manufacturing of larger tablet images. However, due their unique size, some adjustments and special considerations to the manufacturing techniques and analytical tests may be required. Case studies dealing with some of these considerations will be discussed here, along with current thoughts and perspectives of the challenges and opportunities of using minitablets.
Speakers:
Francis J. Flanagan Jr., Associate Principal Scientist, Preclinical Development, Merck & Co. Inc.
Varsha Biyyala, Sr. Scientist, Formulation Sciences, Merck & Co. Inc.
To register: http://www.interphex.com/pharmtech
Other presentations in this session:
1–1:30 pm
Drop-On-Demand Manufacturing System for the Flexible Production of Solid Oral Dosage Forms
1:40–2:10 pm
Polymer Thin Films for Drug Delivery: Process and PAT Development
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Fast and Efficient Sialic Acid Clone Selection Using Lectin-Based High-Throughput Screening
June 2nd 2025Glycosylation is a common and critical post-translational modification that affects protein function and therapeutic efficacy, making its monitoring and accurate quantification essential for drug development.
